These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31157865)

  • 21. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Tarasewicz A; Dębska-Ślizień A; Rutkowski B
    Transplant Proc; 2016 Jun; 48(5):1650-3. PubMed ID: 27496465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
    Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
    Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.
    Kumar D; Chernenko S; Moussa G; Cobos I; Manuel O; Preiksaitis J; Venkataraman S; Humar A
    Am J Transplant; 2009 May; 9(5):1214-22. PubMed ID: 19422346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis.
    Ali H; Soliman KM; Shaheen I; Kim JJ; Kossi ME; Sharma A; Pararajasingam R; Halawa A
    Int Urol Nephrol; 2020 Apr; 52(4):791-802. PubMed ID: 32170593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
    Banas B; Steubl D; Renders L; Chittka D; Banas MC; Wekerle T; Koch M; Witzke O; Mühlfeld A; Sommerer C; Habicht A; Hugo C; Hünig T; Lindemann M; Schmidt T; Rascle A; Barabas S; Deml L; Wagner R; Krämer BK; Krüger B
    Transpl Int; 2018 Apr; 31(4):436-450. PubMed ID: 29284181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of More Vulnerable Patients for Cytomegalovirus Infection in Renal Transplant Recipients With Antithymocyte Globulin Induction Therapy: An Analysis of Risk Factors and Cell-Mediated Immunity.
    Jun KW; Lim JH; Hwang JK; Park SC; Kim JI; Yun SS; Kim MH
    Transplant Proc; 2021 Sep; 53(7):2252-2260. PubMed ID: 34452738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular immunity against cytomegalovirus and risk of infection after kidney transplantation.
    Blom KB; Kro GB; Midtvedt K; Jenssen TG; Reisæter AV; Rollag H; Hartmann A; Sagedal S; Sjaastad I; Tylden G; Njølstad G; Nilsen E; Birkeland JA; Åsberg A
    Front Immunol; 2024; 15():1414830. PubMed ID: 39007131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection.
    Schachtner T; Stein M; Reinke P
    Transpl Int; 2016 Dec; 29(12):1296-1306. PubMed ID: 27638250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.
    Kaminski H; Couzi L; Garrigue I; Moreau JF; Déchanet-Merville J; Merville P
    Am J Transplant; 2016 Aug; 16(8):2384-94. PubMed ID: 26953216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
    Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
    Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of anti-thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis.
    Basso G; Felipe CR; Cristelli MP; Mansur Siliano J; Viana L; Ferreira Brigido AN; Stopa Martins SB; de Castro Lima Santos DW; Aguiar WF; Tedesco-Silva Junior H; Medina-Pestana JO
    Transpl Infect Dis; 2018 Aug; 20(4):e12919. PubMed ID: 29797676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
    Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
    Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
    Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial.
    Páez-Vega A; Gutiérrez-Gutiérrez B; Agüera ML; Facundo C; Redondo-Pachón D; Suñer M; López-Oliva MO; Yuste JR; Montejo M; Galeano-Álvarez C; Ruiz-San Millan JC; Los-Arcos I; Hernández D; Fernández-Ruiz M; Muñoz P; Valle-Arroyo J; Cano A; Rodríguez-Benot A; Crespo M; Rodelo-Haad C; Lobo-Acosta MA; Garrido-Gracia JC; Vidal E; Guirado L; Cantisán S; Torre-Cisneros J;
    Clin Infect Dis; 2022 Mar; 74(5):757-765. PubMed ID: 34228099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
    Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
    Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-month low-dose valganciclovir prophylaxis in cytomegalovirus D+/R- kidney transplant patients receiving thymoglobulin induction.
    Luan FL
    Transplant Proc; 2013; 45(1):175-7. PubMed ID: 23267799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.